Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $15,000 | 2 | 70.1% |
| Food and Beverage | $3,963 | 94 | 18.5% |
| Travel and Lodging | $2,105 | 6 | 9.8% |
| Education | $330.40 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $16,668 | 17 | $0 (2018) |
| Boston Scientific Corporation | $2,395 | 18 | $0 (2024) |
| Abbott Laboratories | $903.30 | 19 | $0 (2024) |
| Amgen Inc. | $245.75 | 7 | $0 (2022) |
| Allergan, Inc. | $196.26 | 4 | $0 (2021) |
| ABBVIE INC. | $171.79 | 7 | $0 (2024) |
| Nevro Corp. | $155.05 | 2 | $0 (2019) |
| PFIZER INC. | $146.05 | 2 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $93.78 | 6 | $0 (2021) |
| Lundbeck LLC | $87.21 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $336.98 | 15 | Abbott Laboratories ($135.51) |
| 2023 | $159.41 | 8 | ABBVIE INC. ($68.56) |
| 2022 | $162.08 | 8 | Lundbeck LLC ($50.75) |
| 2021 | $276.59 | 15 | Collegium Pharmaceutical, Inc. ($47.43) |
| 2020 | $45.26 | 3 | Allergan, Inc. ($16.39) |
| 2019 | $92.49 | 6 | Collegium Pharmaceutical, Inc. ($30.05) |
| 2018 | $5,224 | 24 | Medtronic USA, Inc. ($4,228) |
| 2017 | $15,102 | 27 | Medtronic USA, Inc. ($12,440) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.81 | General |
| 12/02/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Pain Management | ||||||
| 10/22/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.56 | General |
| 10/03/2024 | Abbott Laboratories | AXIUM (Device) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Neuromodulation | ||||||
| 10/01/2024 | Abbott Laboratories | AXIUM (Device) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Neuromodulation | ||||||
| 09/13/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $42.49 | General |
| Category: Neuromodulation | ||||||
| 09/13/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Neuromodulation | ||||||
| 09/13/2024 | Abbott Laboratories | AXIUM (Device) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Neuromodulation | ||||||
| 08/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: PAIN | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.75 | General |
| 04/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Neuromodulation | ||||||
| 04/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Neuromodulation | ||||||
| 11/30/2023 | EAGLE PHARMACEUTICALS, INC. | BARHEMSYS (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Post Operative Nausea and Vomiting | ||||||
| 10/09/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: NEUROLOGY | ||||||
| 08/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/13/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/20/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Neuromodulation | ||||||
| 11/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Gastroenterology | ||||||
| 10/31/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,531 | 6,066 | $1.7M | $266,242 |
| 2022 | 26 | 2,911 | 6,957 | $2.2M | $352,058 |
| 2021 | 26 | 3,478 | 9,329 | $2.3M | $363,292 |
| 2020 | 29 | 4,118 | 9,165 | $2.1M | $302,619 |
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 444 | 796 | $250,520 | $68,703 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 390 | 634 | $150,204 | $38,617 | 25.7% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 303 | 340 | $250,920 | $38,004 | 15.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 363 | 410 | $162,490 | $24,849 | 15.3% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 67 | 68 | $52,632 | $13,056 | 24.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 26 | 26 | $65,488 | $12,239 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $42,880 | $11,805 | 27.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 42 | 54 | $35,976 | $9,327 | 25.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 28 | 47 | $143,000 | $8,561 | 6.0% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 14 | 14 | $32,648 | $6,617 | 20.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 25 | 25 | $32,144 | $6,368 | 19.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 30 | 35 | $70,100 | $6,121 | 8.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 33 | 41 | $65,376 | $5,246 | 8.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 28 | 47 | $57,860 | $4,555 | 7.9% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 14 | 14 | $13,592 | $3,850 | 28.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 29 | 36 | $11,296 | $2,740 | 24.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 33 | 39 | $8,985 | $2,043 | 22.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 33 | $6,180 | $1,282 | 20.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 16 | 20 | $9,096 | $854.62 | 9.4% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 12 | 13 | $5,330 | $474.99 | 8.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 109 | 109 | $1,587 | $320.76 | 20.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 170 | 2,443 | $185,746 | $233.19 | 0.1% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 107 | 107 | $1,557 | $180.42 | 11.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 27 | 41 | $3,362 | $131.61 | 3.9% |
| J2704 | Injection, propofol, 10 mg | Office | 2023 | 45 | 511 | $41,902 | $43.46 | 0.1% |
About John Gardner
John Gardner is a Anesthesiology healthcare provider based in Franklin, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1770826299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Gardner has received a total of $21,399 in payments from pharmaceutical and medical device companies, with $336.98 received in 2024. These payments were reported across 106 transactions from 24 companies. The most common payment nature is "Grant" ($15,000).
As a Medicare-enrolled provider, Gardner has provided services to 13,038 Medicare beneficiaries, totaling 31,517 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Franklin, KY
- Active Since 04/03/2013
- Last Updated 03/25/2024
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1770826299
Products in Payments
- ADAPTIVESTIM (Device) $15,000
- PRECISION (Device) $1,473
- SYNCHROMED (Device) $1,043
- SPECTRA WAVEWRITER (Device) $529.20
- SCS IPGs (Device) $399.19
- N'VISION (Device) $251.11
- GENERAL - PAIN MANAGEMENT (Device) $235.97
- Aimovig (Biological) $223.23
- INTELLIS (Device) $173.51
- Proclaim Family of SCS IPGs (Device) $165.94
- Senza Spinal Cord Stimulation System (Device) $155.05
- BOTOX CHRONIC MIGRAINE (Drug) $147.55
- BOTOX (Biological) $144.58
- RESTORE (Device) $141.22
- PROCLAIM (Device) $128.84
- DRG IPGs (Device) $127.46
- EMBEDA (Drug) $121.35
- SPECTRA SYSTEM (Device) $120.32
- XTAMPZA (Drug) $93.78
- VYEPTI (Biological) $87.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Franklin
Dr. Mark Zimmerman, M.d, M.D
Anesthesiology — Payments: $36,628
Dr. Matthew Mcevoy, Md, MD
Anesthesiology — Payments: $15,960
Dr. Douglas Milosavljevic, M.d, M.D
Anesthesiology — Payments: $7,537
Edgar Martinez, Md, MD
Anesthesiology — Payments: $3,495
Kenneth Lanyon, Md, MD
Anesthesiology — Payments: $1,279
David Vickers, Md, MD
Anesthesiology — Payments: $513.85